Zhu-tao Wang
Key Laboratory For Carcinogenesis And Cancer Invasion, 180 Fenglin Road
Zhongshan, 200032, China
Zhongshan, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Cystatin B Promotes the Proliferation, Migration, and Invasion of Intrahepatic Cholangiocarcinoma.
Journal: Current oncology (Toronto, Ont.)
Published: November 21, 2024
Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis.
Journal: Cancer medicine
Published: May 15, 2024
Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma.
Journal: Journal of cancer research and clinical oncology
Published: May 10, 2024
Interleukin 35 promotes progression of hepatocellular carcinoma by recruiting neutrophils.
Journal: Translational oncology
Published: April 03, 2024
Enhancing hepatocellular carcinoma management: prognostic value of integrated CCL17, CCR4, CD73, and HHLA2 expression analysis.
Journal: Journal of cancer research and clinical oncology
Published: March 10, 2024
Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma.
Journal: World journal of surgical oncology
Published: December 09, 2022
The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: October 08, 2022
MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway.
Journal: Clinical immunology (Orlando, Fla.)
Published: September 27, 2022
Deep-learning-based analysis of preoperative MRI predicts microvascular invasion and outcome in hepatocellular carcinoma.
Journal: World journal of surgical oncology
Published: March 10, 2022
Dissecting Intra-Tumoral Changes Following Immune Checkpoint Blockades in Intrahepatic Cholangiocarcinoma via Single-Cell Analysis.
Journal: Frontiers in immunology
Published: February 24, 2022
Antiviral therapy improves postoperative survival of patients with HBV-related hepatocellular carcinoma.
Journal: American journal of surgery
Published: November 22, 2021
BRG1 regulates lipid metabolism in hepatocellular carcinoma through the PIK3AP1/PI3K/AKT pathway by mediating GLMP expression.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: February 21, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026